Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent toxoplasmosis.

R Norrby, T Eilard

    Scandinavian Journal of Infectious Diseases
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Recurrent toxoplasmosis can occur even after multiple treatments with co-trimoxazole. This case highlights that toxoplasmosis may remain latent and reactivate, particularly with other illnesses or weakened immunity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The impact of vaccines on public health: the role of ESCMID.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
    Same author

    Outlook for a dengue vaccine.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
    Same author

    General summing up.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Pharmacokinetic and clinical studies on cefuroxime.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Public health. The cholera crisis in Africa.

    Science (New York, N.Y.)·2009
    Same author

    Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.

    Scandinavian journal of infectious diseases·2001
    Same journal

    Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

    Scandinavian journal of infectious diseases·2017
    Same journal

    Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

    Scandinavian journal of infectious diseases·2017
    Same journal

    Fatal varicella pneumonia.

    Scandinavian journal of infectious diseases·2015
    Same journal

    Wissler's Syndrome Associated with Parainfluenza 2 Infection.

    Scandinavian journal of infectious diseases·2015
    Same journal

    Contamination of smears with "sergentella spiroides".

    Scandinavian journal of infectious diseases·2015
    Same journal

    Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

    Scandinavian journal of infectious diseases·2015
    See all related articles

    Area of Science:

    • Medical Parasitology
    • Infectious Diseases
    • Immunology

    Background:

    • Toxoplasmosis is a common parasitic infection.
    • Co-trimoxazole is a standard treatment for toxoplasmosis.
    • Recurrence suggests potential challenges in complete eradication.

    Observation:

    • A previously healthy 34-year-old woman experienced recurrent toxoplasmosis.
    • She received three courses of co-trimoxazole with initial clinical and serological improvement.
    • Despite treatment, she relapsed with symptoms and rising anti-toxoplasma antibody titers.

    Findings:

    • Co-trimoxazole, while effective, may not prevent relapse in all cases of toxoplasmosis.
    • Recurrent toxoplasmosis indicates the parasite's ability to persist and reactivate.

    Related Experiment Videos

  • Serological markers confirmed reinfection or reactivation.

    • Implications:

    • Toxoplasmosis may establish a latent infection, susceptible to reactivation.
    • Factors like concurrent diseases or immunodepression could trigger reactivation.
    • Further research is needed on long-term management and prevention of toxoplasmosis recurrence.